Iron dextran route of administration
Iron dextran is approved for parenteral administration via intramuscular (IM) injection. [1]
FDA-labeled intramuscular administration
INFeD (iron dextran injection) is labeled for use via intravenous or intramuscular injection. [1]
Test dose requirement for first IM dose
For the first intramuscular INFeD therapeutic dose, an intramuscular test dose of 0.5 mL is recommended. [2]
Practical administration considerations
Iron dextran injection is supplied in a form intended for intramuscular or intravenous use. [1]
Safety monitoring for IM administration
Anaphylactic-type reactions have been reported with iron dextran products, which requires appropriate monitoring in a medical setting. [3]
Clinical caveat on product selection
Route-of-administration approval depends on the specific iron dextran product formulation and labeling. [1]